Hybrid Liposome–U87MG Membrane Nanovesicles Enhance Brain Delivery and Therapeutic Efficacy of Irinotecan in Orthotopic Glioma
Background The blood–brain barrier (BBB) and hydrolytic inactivation of the lactone form limit the efficacy of irinotecan (CPT-11) against glioma. To address these challenges, we developed a CPT-11-loaded hybrid liposome–U87MG cell membrane nanovesicle formulation (Hybrid/CPT-11), an underexplored biomimetic strategy f...